Open access policy

Arthritis Research UK and other leading UK medical research charities have formed an alliance to launch a new fund to help make publicly-funded research freely available as soon as it is published. Together these partners are providing around £12 million to fund the two-year pilot of the Charity Open Access Fund (COAF).

COAF has been established for an initial pilot phase of two years, beginning 1 October 2014. The Wellcome Trust is administering the Fund on behalf of the partners for this pilot phase.

The Charity Open Access Fund (COAF) is a partnership between Arthritis Research UK, Breast Cancer Campaign, the British Heart Foundation, Cancer Research UK, Leukaemia & Lymphoma Research and the Wellcome Trust to enable free and unrestricted access to the published outputs of the research we support.

COAF will provide single combined block grants to 36 UK research institutions to meet open access article processing charges for peer-reviewed research publications resulting from research funded by one or more of the six partner charities.

Authors supported by research funding from Arthritis Research UK, but based at an institution which is not supported by COAF, can still apply to Arthritis Research UK for open access funding if their host institution is unable to meet these costs. This can be done as detailed in our step by step guide to making your paper open access.

Arthritis Research UK is committed to ensuring that the published results of its research are made as freely and widely available as possible, independent of the journal subscriptions that their institution offers. It is a condition of funding that all original papers published from research that is wholly or substantially funded by Arthritis Research UK are deposited in the open access repositories PubMed Central (PMC) and PMC’s linked sister repository Europe PubMed Central (Europe PMC) within six months of publication. This policy does not extend to reviews, book chapters, editorials or conference proceedings.